This antibody pair is designed for detection of SARS-CoV-2 antigens. The antibodies are selected for high affinity and specificity, supporting sensitive and rapid lateral flow diagnostic assays.
Applications
Lateral Flow Assay (LFA)
Principle of Assay
In a lateral flow assay, the labeled detection antibody binds SARS-CoV-2 antigen in the sample to form a complex. The complex migrates along the membrane and is captured at the test line, producing a visible signal proportional to antigen concentration.
Sample Type
Nasal swab, nasopharyngeal swab, throat swab, saliva, or extracted specimen depending on target antigen
Cross Reactivity
Does not cross-react with CoV nucleoproteins: 229E, HKU1, NL63 and OC43.
Conjugate
Unconjugated
Purity
>90%.
Concentration
Lot Specific
Product Form
Supplied in liquid format. Please note that the size ordered refers to the total combined quantity of both antibodies.
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Short term (1 week) store at 4°C. Long term store below -20°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Schematic representation of a lateral flow assay using a matched antibody pair. Following application to the sample pad, the sample rehydrates labeled detection antibodies, which bind the target analyte if present. The resulting complexes migrate along the nitrocellulose membrane by capillary action. At the test line, immobilized capture antibodies bind the analyte-detection antibody complex, forming a sandwich and generating a visible signal. Excess labeled detection antibodies continue to migrate and are captured at the control line by anti-species antibodies, confirming proper assay function, while the absorbent pad maintains continuous flow across the strip. The analyte is represented by a blue shape, the detection antibody by a purple Y conjugated to a gold particle, the capture antibody by a blue Y, the control line antibody by a green Y, and the label by a gold particle (e.g. colloidal gold or latex).
Publishing research using Anti-SARS-CoV-2 Matched Antibody Pair (A325487)? Please let us know so that we can list the citation on this page.